A Study of Patient Characteristics and Treatment Patterns in Real-world Melanoma Patients Treated With Dabrafenib and Trametinib or Encorafenib and Binimetinib in Japan
Clinical trial NCT07649252 · COMPLETED
Trial details
- NCT number
- NCT07649252
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-01
- Primary completion
- 2022-11-20
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.